Education/CredentialsFellowship : University of California, Irvine (Gynecologic Oncology )Master's Degree: University of California, Irvine (Biomedical and Translational Science (MS-BATS))Residency : University of California. Irvine (Obstetrics and Gynecology )Medical Degree: Marshall University School of Medicine (Medicine )Master's Degree: University of Pennsylvania Master's Degree: University of Pennsylvania (Landscape Architecture and Regional Planning (MLARP))Bachelor's Degree : University of Florida (Architecture ) Board Certifications & LicensesAmerican Board of Obstetrics and Gynecology (Certification Date: 2021-05-14) - (Recertification Date: 2022-12-31) SpecialtiesGynecologic OncologyObstetrics and Gynecology Contact Information Medical Sciences Building Email wolforje@ucmail.uc.edu Clinical Interests Obstetrics and Gynecology Peer Reviewed Publications Wolford, Juliet E; Ferrigni, Erin; Margul, Daniel; Herzog, Thomas J 2022. Integrating Precision Medicine into the Contemporary Management of Gynecologic Cancers. Current oncology reports, 24 7, 889-904Clair, Kiran H; Wolford, Juliet; Zell, Jason A; Bristow, Robert E 2021. Surgical Management of Gynecologic Cancers. Surgical oncology clinics of North America, 30 1, 69-88Coakley, Katherine; Wolford, Juliet; Tewari, Krishnansu 2020. Fertility preserving treatment for gynecologic malignancies: a review of recent literature. Current opinion in obstetrics & gynecology, 32 1, 51-56Ford, Lindsey; Wolford, Juliet E; Brown, Sandra M; Randall, Leslie M 2020. A profile on the FoundationFocus CDxBRCA tests. Expert review of molecular diagnostics, 20 3, 285-292Liu, Marisa C; Gardner, Austin B; Wolford, Juliet E; Tewari, Krishnansu S 2020. Endometrial cancer in the morbidly obese: a review. Current opinion in obstetrics & gynecology, 32 1, 42-50Wolford, Juliet E; Bai, Jiaru; Moore, Kathleen N; Kristeleit, Rebecca; Monk, Bradley J; Tewari, Krishnansu S 2020. Cost-effectiveness of niraparib, rucaparib, and olaparib for treatment of platinum-resistant, recurrent ovarian carcinoma. Gynecologic oncology, 157 2, 500-507Wolford, Juliet E; Tewari, Krishnansu S 2018. Rational design for cervical cancer therapeutics: cellular and non-cellular based strategies on the horizon for recurrent, metastatic or refractory cervical cancer. Expert opinion on drug discovery, 13 5, 445-457Clair, Kiran; Wolford, Juliet; Veran-Taguibao, Sonia; Kim, Grace; Eskander, Ramez N 2017. Primary low-grade endometrial stromal sarcoma of the omentum. Gynecologic oncology reports, 21 , 119-121Wolford, Juliet E; Tewari, Krishnansu S 2017. Highlights from the Gynecologic Oncology Track at the 2017 Annual Meeting of the American Society of Clinical Oncology. Journal of gynecologic oncology, 28 5, e74Wolford, Juliet E; Tewari, Krishnansu S 2015. US FDA oncology drug approvals in 2014. Future oncology (London, England), 11 13, 1931-45McGuffin, Aaron; Vaughan, Amy; Wolford, Juliet . Urticarial Vasculitis in a Teenage Girl. Journal of investigative medicine high impact case reports, 1 2, 2324709613484301
Peer Reviewed Publications Wolford, Juliet E; Ferrigni, Erin; Margul, Daniel; Herzog, Thomas J 2022. Integrating Precision Medicine into the Contemporary Management of Gynecologic Cancers. Current oncology reports, 24 7, 889-904Clair, Kiran H; Wolford, Juliet; Zell, Jason A; Bristow, Robert E 2021. Surgical Management of Gynecologic Cancers. Surgical oncology clinics of North America, 30 1, 69-88Coakley, Katherine; Wolford, Juliet; Tewari, Krishnansu 2020. Fertility preserving treatment for gynecologic malignancies: a review of recent literature. Current opinion in obstetrics & gynecology, 32 1, 51-56Ford, Lindsey; Wolford, Juliet E; Brown, Sandra M; Randall, Leslie M 2020. A profile on the FoundationFocus CDxBRCA tests. Expert review of molecular diagnostics, 20 3, 285-292Liu, Marisa C; Gardner, Austin B; Wolford, Juliet E; Tewari, Krishnansu S 2020. Endometrial cancer in the morbidly obese: a review. Current opinion in obstetrics & gynecology, 32 1, 42-50Wolford, Juliet E; Bai, Jiaru; Moore, Kathleen N; Kristeleit, Rebecca; Monk, Bradley J; Tewari, Krishnansu S 2020. Cost-effectiveness of niraparib, rucaparib, and olaparib for treatment of platinum-resistant, recurrent ovarian carcinoma. Gynecologic oncology, 157 2, 500-507Wolford, Juliet E; Tewari, Krishnansu S 2018. Rational design for cervical cancer therapeutics: cellular and non-cellular based strategies on the horizon for recurrent, metastatic or refractory cervical cancer. Expert opinion on drug discovery, 13 5, 445-457Clair, Kiran; Wolford, Juliet; Veran-Taguibao, Sonia; Kim, Grace; Eskander, Ramez N 2017. Primary low-grade endometrial stromal sarcoma of the omentum. Gynecologic oncology reports, 21 , 119-121Wolford, Juliet E; Tewari, Krishnansu S 2017. Highlights from the Gynecologic Oncology Track at the 2017 Annual Meeting of the American Society of Clinical Oncology. Journal of gynecologic oncology, 28 5, e74Wolford, Juliet E; Tewari, Krishnansu S 2015. US FDA oncology drug approvals in 2014. Future oncology (London, England), 11 13, 1931-45McGuffin, Aaron; Vaughan, Amy; Wolford, Juliet . Urticarial Vasculitis in a Teenage Girl. Journal of investigative medicine high impact case reports, 1 2, 2324709613484301
Wolford, Juliet E; Ferrigni, Erin; Margul, Daniel; Herzog, Thomas J 2022. Integrating Precision Medicine into the Contemporary Management of Gynecologic Cancers. Current oncology reports, 24 7, 889-904Clair, Kiran H; Wolford, Juliet; Zell, Jason A; Bristow, Robert E 2021. Surgical Management of Gynecologic Cancers. Surgical oncology clinics of North America, 30 1, 69-88Coakley, Katherine; Wolford, Juliet; Tewari, Krishnansu 2020. Fertility preserving treatment for gynecologic malignancies: a review of recent literature. Current opinion in obstetrics & gynecology, 32 1, 51-56Ford, Lindsey; Wolford, Juliet E; Brown, Sandra M; Randall, Leslie M 2020. A profile on the FoundationFocus CDxBRCA tests. Expert review of molecular diagnostics, 20 3, 285-292Liu, Marisa C; Gardner, Austin B; Wolford, Juliet E; Tewari, Krishnansu S 2020. Endometrial cancer in the morbidly obese: a review. Current opinion in obstetrics & gynecology, 32 1, 42-50Wolford, Juliet E; Bai, Jiaru; Moore, Kathleen N; Kristeleit, Rebecca; Monk, Bradley J; Tewari, Krishnansu S 2020. Cost-effectiveness of niraparib, rucaparib, and olaparib for treatment of platinum-resistant, recurrent ovarian carcinoma. Gynecologic oncology, 157 2, 500-507Wolford, Juliet E; Tewari, Krishnansu S 2018. Rational design for cervical cancer therapeutics: cellular and non-cellular based strategies on the horizon for recurrent, metastatic or refractory cervical cancer. Expert opinion on drug discovery, 13 5, 445-457Clair, Kiran; Wolford, Juliet; Veran-Taguibao, Sonia; Kim, Grace; Eskander, Ramez N 2017. Primary low-grade endometrial stromal sarcoma of the omentum. Gynecologic oncology reports, 21 , 119-121Wolford, Juliet E; Tewari, Krishnansu S 2017. Highlights from the Gynecologic Oncology Track at the 2017 Annual Meeting of the American Society of Clinical Oncology. Journal of gynecologic oncology, 28 5, e74Wolford, Juliet E; Tewari, Krishnansu S 2015. US FDA oncology drug approvals in 2014. Future oncology (London, England), 11 13, 1931-45McGuffin, Aaron; Vaughan, Amy; Wolford, Juliet . Urticarial Vasculitis in a Teenage Girl. Journal of investigative medicine high impact case reports, 1 2, 2324709613484301